CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

– The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN – If approved by the European Commission, ELZONRIS will be the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, in Europe The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced […]

thaipr.net

16 พ.ย. 63

AMOS appoints new CEO to lead its next phase of transformation and growth

– Venkatraman Sheshashayee is appointed as Acting CEO with immediate effect– Mr Sheshashayee will lead AMOS’ strategy to ‘transform and grow’ by improving operational efficiency, driving modernization and deepening customer touchpoints AMOS Group Limited (“AMOS”), a supplier of products, services, and solutions to the Marine and Energy industries, today announces the appointment of Venkatraman…

thaipr.net

16 พ.ย. 63
1 3,026 3,027 3,028 3,029